The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

EU-wide position versus national implementation

This is a generated summary. It shows the 5 most-liked posts from a topic of 30, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
BB
b.brandtTL217 Apr 2025#1

EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did.

Eu-wide position versus national implementation: what I expected, what I found, and the gap between them.

I am posting the gap rather than a theory about it. My theories about gaps like this one have not held up well.

36 likes 15mo
VK
v.kirchnerTL216 May 2025#5
coldchain_liu, post #2: I will take the caveat as seriously as the claim, which is the point of putting it there. Go to post

Where a national body publishes clinical guidance, that document determines the practical answer more than the authorisation does.

It reads as pedantry until the day it does not.

26 likes in reply to #2 14mo
AF
a.finnegan_rdTL2Dietitian Solution1 Jun 2025 · edited#8

Prescription status is harmonised at the level of the authorisation and the practical route to a prescription is not.

7 likes 14mo
NK
ni.kravchenkoTL220 Jun 2025#12

Summarising the eu-wide position versus national implementation thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.

27 likes 13mo
CL
coldchain_liuTL3Regular20 Jul 2025#19

Adding a note of thanks rather than an opinion. I did not know most of that.

26 likes 12mo

Read the full topic (30 posts)

Promoted into the documentation commons. The content of this topic is maintained at Access notes: Spain, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
About the European Union category
EMA positions, national differences within the EU, and cross-border purchase rules. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
SLTVGRPTC+1 5 18k 10mo
[2026 update] EU-wide position versus national implementation
On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. A methods question rather than a substantive one, about eu-wide position versus national…
FIANDT 2 54k 19mo
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. Cross-border purchase rules within — I have the observation and I do not trust my…
JEDBNRPFFE+12 16 2.8k 11mo
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
YISVCDAMB+70 74 7k 8mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…
SFJSREBS+7 11 39k 3mo

Related topics — sharing the tags EMA, personal import, cost per milligram

TopicParticipantsRepliesViewsActivity
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. Working notes on List price versus negotiated price rather than a…
VKBVIABDGR+24 28 50k 12mo
Second pass at: Manufacturer assistance programmes and their eligibility rules
Second pass at: Manufacturer assistance programmes and their eligibility rules — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
JDLAPOHNKK+13 17 1.8k 16mo
Irish differences from the UK position — what changed since
Irish differences from the UK position — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Irish differences is wrong? I ask…
DOFNTIANPM+8 12 782 1d
External review after an internal denial
External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…
CNLGRM 2 18k 1mo
Cross-border purchase within the EU: the actual rules
Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on cross-border…
SCMIBVET+6 10 41k 11mo